Heterocyclic sulfonamide derivatives useful as MEK inhibitors

Details for Australian Patent Application No. 2010317167 (hide)

Owner Novartis AG

Inventors Bock, Mark G.; Chikkanna, Dinesh; McCarthy, Clive; Moebitz, Henrik; Pandit, Chetan

Agent Davies Collison Cave

Pub. Number AU-A-2010317167

PCT Pub. Number WO2011/054828

Priority 2678/CHE/2009 04.11.09 IN

Filing date 2 November 2010

Wipo publication date 12 May 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4355 (2006.01)

A61K 31/4365 (2006.01)

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/054828 Priority application(s): WO2011/054828

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010317170-Precipitated magnesium carbonate

2010317166-Process for the preparation of Calcobutrol